ARCHIVES

Economic Analyses Of New Therapies Useful In Phase III Studies, Trialists Say

This article is from The Cancer Letter archive.

Vol. 35 No. 29 | July 24, 2009

Download PDF Visit The Full Archive

Related Articles

In Brief: Pretreatment Critical In Antimetic Therapy, Sallan Says; Aging/Cancer Symposium Planned

July 11, 1980

NCI Advisory Group Meetings for September

August 29, 1975

Murphy Puts RPMI On Record

July 22, 1977

SOCMA Asks Congress for Carcinogen Classification Probe

March 25, 1988

Morale, Money Woes Hit MD Anderson

January 18, 2013

“The One Thing You Want From AN NCI Director: He Will Be Bound By The Facts”

October 28, 1994